Tania Bubela [4]T. Bubela [1]
  1.  18
    Introduction: Sharing Data in a Medical Information Commons.Amy L. McGuire, Mary A. Majumder, Angela G. Villanueva, Jessica Bardill, Juli M. Bollinger, Eric Boerwinkle, Tania Bubela, Patricia A. Deverka, Barbara J. Evans, Nanibaa' A. Garrison, David Glazer, Melissa M. Goldstein, Henry T. Greely, Scott D. Kahn, Bartha M. Knoppers, Barbara A. Koenig, J. Mark Lambright, John E. Mattison, Christopher O'Donnell, Arti K. Rai, Laura L. Rodriguez, Tania Simoncelli, Sharon F. Terry, Adrian M. Thorogood, Michael S. Watson, John T. Wilbanks & Robert Cook-Deegan - 2019 - Journal of Law, Medicine and Ethics 47 (1):12-20.
    Drawing on a landscape analysis of existing data-sharing initiatives, in-depth interviews with expert stakeholders, and public deliberations with community advisory panels across the U.S., we describe features of the evolving medical information commons. We identify participant-centricity and trustworthiness as the most important features of an MIC and discuss the implications for those seeking to create a sustainable, useful, and widely available collection of linked resources for research and other purposes.
    Direct download (3 more)  
    Export citation  
    Bookmark   3 citations  
  2.  8
    Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada.Tania Bubela, Shelagh K. Genuis, Naveed Z. Janjua, Mel Krajden, Nicole Mittmann, Katerina Podolak & Lawrence W. Svenson - 2019 - Journal of Law, Medicine and Ethics 47 (1):97-105.
    We explore how principles predicting the success of a medical information commons advantaged or disadvantaged three MIC initiatives in three Canadian provinces. Our MIC case examples demonstrate that practices and policies to promote access to and use of health information can help improve individual healthcare and inform a learning health system. MICs were constrained by heterogenous health information protection laws across jurisdictions and risk-averse institutional cultures. A networked approach to MICs would unlock even more potential for national and international data (...)
    Direct download (2 more)  
    Export citation  
    Bookmark   2 citations  
  3.  36
    Why a Criminal Ban? Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate.Timothy Caulfield & Tania Bubela - 2007 - American Journal of Bioethics 7 (2):51 – 61.
    Somatic cell nuclear transfer (SCNT) remains a controversial technique, one that has elicited a variety of regulatory responses throughout the world. On March 29, 2005, Canada's Assisted Human Reproduction Act came into force. This law prohibits a number of research activities, including SCNT. Given the pluralistic nature of Canadian society, the creation of this law stands as an interesting case study of the policy-making process and how and why a liberal democracy ends up making the relatively rare decision to use (...)
    Direct download (3 more)  
    Export citation  
    Bookmark   8 citations  
  4.  55
    Molecular Typing Technology: A Legal Perspective.T. Bubela & S. Yanow - 2012 - Public Health Ethics 5 (3):317-320.
    This response to Rump and Woonink (2012) on ethical questions concerning the use of molecular typing techniques in the control of infectious diseases examines the use of typing in Canada and the legal framework that will govern its increasing use for source and contact tracing in provincial health systems. It examines whether current public health and privacy laws and constitutional protections provide the appropriate balance between public and individual interests in the control of infectious diseases.
    Direct download (9 more)  
    Export citation  
  5.  13
    Ocular Gene Transfer in the Spotlight: Implications of Newspaper Content for Clinical Communications.Shelly Benjaminy & Tania Bubela - 2014 - BMC Medical Ethics 15 (1):58.
    Ocular gene transfer clinical trials are raising hopes for blindness treatments and attracting media attention. News media provide an accessible health information source for patients and the public, but are often criticized for overemphasizing benefits and underplaying risks of novel biomedical interventions. Overly optimistic portrayals of unproven interventions may influence public and patient expectations; the latter may cause patients to downplay risks and over-emphasize benefits, with implications for informed consent for clinical trials. We analyze the news media communications landscape about (...)
    Direct download (6 more)  
    Export citation